Patient Care

Metformin Continues to Be First-Line Therapy for Type 2 Diabetes


Clinical question: Which medications are most safe and effective at managing type 2 diabetes?

Background: Patients and practitioners need an updated review of the evidence to select the optimal medication for type 2 diabetes management.

Study design: Systematic review.

Synopsis: The authors reviewed 179 trials and 25 observational studies. When comparing metformin to sulfonylureas, metformin was associated with less cardiovascular mortality.

However, when trying to make comparisons based on all-cause mortality or microvascular complications, the evidence is limited. Improvements in hemoglobin A1c levels are similar when comparing different monotherapy options, and low blood sugar was most common with sulfonylureas. The short duration of many trials limits the ability to provide better data on long-term outcomes.

Bottom line: Metformin remains the first-line agent for type 2 diabetes management.

Citation: Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systemic review and meta-analysis. Ann Intern Med. 2016;164(1):740-751.

Short Take

Patients Discharge Readiness May Not Be Adequately Assessed and/or Addressed During Hospitalization

Prospective observational study found unresolved barriers to discharge were common in at least 90% of patients. Patients frequently cited issues including unresolved pain, lack of understanding around discharge plans, and ability to provide self-care.

Citation: Harrison JD, Greysen RS, Jacolbia R, Nguyen A, Auerbach AD. Not ready, not set…discharge: patient-reported barriers to discharge readiness at an academic medical center [published online ahead of print April 15, 2016]. J Hosp Med. doi:10.1002/jhm.2591.

Recommended Reading

SHM Brief Cited in Supreme Court Decision on Abortion Restrictions
The Hospitalist
Successfully Quitting Smoking May Take Many Attempts
The Hospitalist
Reevaluating Cardiovascular Risk after TIA
The Hospitalist
Protein-Based Risk Score Improves Prediction of Cardiovascular Events
The Hospitalist
Preorder 2016 State of Hospital Medicine Report
The Hospitalist
New SHM Members – July 2016
The Hospitalist
Effective Applications of Medication-Assisted Opioid Dependence Counseling
The Hospitalist
New HCV Diagnostic Tests Provide Accuracy and Low Costs
The Hospitalist
Hospitalist Jill Slater Waldman, MD, SFHM, Watched the Field Grow Up But Thinks Peers Deserve More Credit
The Hospitalist
LETTER: 6 Tips When Practicing Telemedicine
The Hospitalist
   Comments ()